Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fixed vs Flexible Filgrastim in Children With Cancer
NCT01987596Phase 3Terminated
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- Aug 2013
- Primary completion
- Jun 2018
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of filgrastim in neutropenia, sponsored by Barbara Ann Karmanos Cancer Institute. Started Aug 2013; status: terminated.
02
Drugs
filgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT01987596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01987596.